First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara VectorLindsey R. Baden, Kelly Stanley, Marinela Kirilova et al.|The Journal of Infectious Diseases|2018Cited by 45
962 A novel alpha-active IL-2-Fc has expanded therapeutic index and robust monotherapy efficacy in mouse cancer models and strong synergy with PD-1 blockadeAdam Stockmann, Ann Cheung, Patrick Kirby et al.|Regular and Young Investigator Award Abstracts|2024Cited by 0
DF6215, an α-optimized IL-2-Fc fusion, expands immune effectors and drives robust preclinical anti-tumor activityAdam Stockmann, Ann Cheung, Stuart W. Hicks et al.|Cell Reports Medicine|2025Cited by 0